-

Shareholder Alert: Robbins LLP Announces Fair Isaac Corporation (FICO) Sued Under the Sherman Act

SAN DIEGO & SAN JOSE, Calif.--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP announces that a consumer of Fair Isaac Corporation (NYSE: FICO) filed a class action complaint against the Company for alleged violations of the Sherman Act and various state antitrust laws between January 1, 2006 to the present. Fair Isaac offers analytical solutions, credit scoring, and credit account management products and services to banks, credit reporting agencies, credit card processing agencies, insurers, retailers, healthcare organizations, and public agencies.

If you suffered a loss as a result of Fair Isaac's misconduct, click here.

Fair Isaac Corporation (FICO) Accused of Antitrust Business Practices

According to the pending class action lawsuit filed against Fair Isaac, for roughly three decades, Fair Isaac has maintained a monopoly over the B2B Credit Score Market in the United States, largely through the unlawfully achieved dominance of its FICO product line. Fair Isaac advertises its monopoly in the B2B Credit Score Market stating that 10 billion FICO scores are sold each year and 90% of all lending decisions in the United States rely on FICO scores, giving the Company the power to control prices. Fair Isaac has also entered into anticompetitive agreements with credit bureaus that restrict their ability to develop or sell other credit scores. These agreements, and Fair Isaac's monopoly and stronghold in the banking industry, have stymied attempts to compete with Fair Isaac, resulting in a disproportionate number of low-income and minority consumers being denied access to credit by Fair Isaac's traditional FICO scoring system and has forced consumers to pay higher prices for credit reports. As a result, on March 15, 2020, Fair Isaac revealed that the Antitrust Division of the U.S. Department of Justice had opened an investigation in its conduct. The lawsuit could result in substantial damages to Fair Isaac causing depletion of its financial resources and harm to shareholders.

Fair Isaac Corporation (FICO) Shareholders Have Legal Options

Contact us to learn more:
Leo Kandinov
(800) 350-6003
lkandinov@robbinsllp.com
Shareholder Information Form

Want to be notified if a class action against Fair Isaac settles? Want to receive free alerts about companies engaged in wrongdoing? Sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Leonid Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

Robbins LLP

NYSE:FICO

Release Versions
$Cashtags

Contacts

Leonid Kandinov
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
LKandinov@robbinsllp.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the uniQure N.V. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired uniQure N.V. (NASDAQ: QURE) ordinary shares between September 24, 2025 and October 31, 2025. uniQure is a biotechnology company developing gene therapies for rare diseases. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Allegations that un...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the POMDoctor Ltd. Securities Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired POMDoctor, Ltd. (NASDAQ: POM) securities between October 9, 2025 and December 11, 2025. POMDoctor claims to be "a leading online medical services platform for chronic diseases in China." For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. The Allegations: Robbins LLP is Investigating Alleg...

Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Inovio Pharmaceuticals, Inc. Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all persons that purchased or otherwise acquired Inovio Pharmaceuticals, Inc. (NASDAQ: INO) securities between October 10, 2023 and December 26, 2025. Inovio is a biotechnology company focused on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with, inter alia, human papillomavirus (“HPV”). For more information, submit a...
Back to Newsroom